Skip to content

Drug interactions

Belzutifan + Eplerenone

Severity: Moderate

Belzutifan and Eplerenone: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Belzutifan can induce CYP3A4, and eplerenone is a CYP3A4 substrate. Exposure to eplerenone may fall, reducing its blood pressure or cardiac benefit.

What this interaction means in plain words

Belzutifan and Eplerenone can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Belzutifan belongs to Miscellaneous; Eplerenone belongs to Cardiovascular.

Evidence level: Moderate

Why it happens

Induction of CYP3A4 by belzutifan, increasing eplerenone metabolism.

What to do

Monitor blood pressure and clinical response to eplerenone, and increase its dose as needed. Re-evaluate the dose if belzutifan is stopped.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Belzutifan and Eplerenone, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Belzutifan with Eplerenone?

MediHelp rates the interaction as moderate. Belzutifan and Eplerenone can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Belzutifan can induce CYP3A4, and eplerenone is a CYP3A4 substrate. Exposure to eplerenone may fall, reducing its blood pressure or cardiac benefit.

How serious is the interaction between Belzutifan and Eplerenone?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood pressure and clinical response to eplerenone, and increase its dose as needed. Re-evaluate the dose if belzutifan is stopped.

What other medicines interact with Eplerenone?

MediHelp also lists interactions of Eplerenone with, for example, Amiloride, Atazanavir, Clarithromycin. The full list is on the Eplerenone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in